Dr. Gevirtz is Clinical Associate Professor, Department of Anesthesiology, Louisiana State University-New Orleans, LA, and Medical Director, Somnia Pain Management, 627 West Street, Harrison, NY 10528; E-mail: [email protected].
Dr. Gevirtz has disclosed that he has no significant relationships with or financial interests in any commercial organizations pertaining to this educational activity.
The author also has disclosed that the use of gabapentin, pregabalin, lamotrigine, 5% lidocaine patch, transdermal fentanyl, oxycodone, morphine, hydromorphone, tramadol, clonidine, and tricyclic antidepressants for treatment of HIV-related pain as discussed in this article has not been approved by the U.S. Food and Drug Administration.
All faculty and staff in a position to control the content of this CME activity have disclosed that they have no financial relationships with, or financial interests in, any commercial companies pertaining to this educational activity.
Lippincott CME Institute, Inc., has identified and resolved all faculty and staff conflicts of interest regarding this educational activity.
